Welcome to our dedicated page for iPath Series B S&P 500 VIX Mid-Term Futures ETN news (Ticker: VXZ), a resource for investors and traders seeking the latest updates and insights on iPath Series B S&P 500 VIX Mid-Term Futures ETN stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect iPath Series B S&P 500 VIX Mid-Term Futures ETN's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of iPath Series B S&P 500 VIX Mid-Term Futures ETN's position in the market.
Barclays Bank PLC has announced an extension of cash tender offers and consent solicitations for four series of its exchange-traded notes (ETNs). The expiration deadline has been extended from November 20, 2024, to January 29, 2025, at 6:00 p.m., New York City time. The tender offers include specific purchase prices for each ETN series, offering premiums above their Closing Indicative Note Values as of November 20, 2024. The affected ETNs include products tracking S&P 500 BuyWrite Index, Bloomberg Livestock, Copper, and Energy indices. The purchase price is payable on February 5, 2025, unless further extended or terminated early.
Barclays Bank PLC has amended the purchase price for certain series of its exchange-traded notes (ETNs) in its ongoing cash tender offers and consent solicitations. The updated purchase prices affect two ETN series: the iPath® CBOE S&P 500 BuyWrite Index ETN at $120.00 (from $110.9504) and the iPath® Bloomberg Livestock Subindex Total Return ETN at $24.00 (from $21.9795). The expiration date remains November 20, 2024, with payment scheduled for November 26, 2024.
The purchase prices reflect a premium to the Closing Indicative Note Value as of November 4, 2024, though they may be lower than the trading price on the expiration date. Previously tendered notes remain valid under the amended terms.
Barclays Bank PLC has announced updates to its cash tender offers and consent solicitations for five series of exchange-traded notes (ETNs). The bank has:
- Determined results for one expired series (iPath® Bloomberg Platinum Subindex Total Return℠ ETN)
- Extended the expiration deadline to November 20, 2024, for four other series
- Amended the purchase price for certain extended series
For the expired series, Barclays accepted 40,542 notes at $22.00 per note, totaling $891,924. The settlement date is October 2, 2024. For the extended series, the purchase prices range from $6.00 to $115.00 per note, reflecting a premium to the Closing Indicative Note Value as of September 25, 2024. Barclays may further amend the offers based on changes in the applicable Closing Index Levels.
Barclays Bank PLC has amended the Purchase Price for certain series of its outstanding exchange-traded notes (ETNs) in its ongoing cash tender offers and consent solicitations. The amended prices apply to the iPath® CBOE S&P 500 BuyWrite IndexSM ETN (BWVTF) and iPath® Bloomberg Platinum Subindex Total ReturnSM ETN (PGMFF). The new Purchase Prices reflect a premium to the Closing Indicative Note Value as of September 10, 2024.
Key points:
- BWVTF: New Purchase Price $115.00 (previous Closing Indicative Value $108.77)
- PGMFF: New Purchase Price $22.00 (previous Closing Indicative Value $18.59)
- Expiration Date remains September 25, 2024
- Payment Date is October 2, 2024, unless extended or terminated early
FAQ